Published in N J Med on July 01, 1996
Effect of nesiritide in patients with acute decompensated heart failure. N Engl J Med (2011) 7.62
Cardiac troponin T levels for risk stratification in acute myocardial ischemia. GUSTO IIA Investigators. N Engl J Med (1996) 5.94
Randomised trials of secondary prevention programmes in coronary heart disease: systematic review. BMJ (2001) 5.63
A systematic review of randomized trials of disease management programs in heart failure. Am J Med (2001) 5.38
Single-bolus tenecteplase compared with front-loaded alteplase in acute myocardial infarction: the ASSENT-2 double-blind randomised trial. Lancet (1999) 4.36
Regional variation across the United States in the management of acute myocardial infarction. GUSTO-1 Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries. N Engl J Med (1995) 4.29
Cost effectiveness of early discharge after uncomplicated acute myocardial infarction. N Engl J Med (2000) 4.19
Cost effectiveness of thrombolytic therapy with tissue plasminogen activator as compared with streptokinase for acute myocardial infarction. N Engl J Med (1995) 3.69
Predictors of outcome in patients with acute coronary syndromes without persistent ST-segment elevation. Results from an international trial of 9461 patients. The PURSUIT Investigators. Circulation (2000) 3.61
Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure. ATLAS Study Group. Circulation (1999) 3.06
Acute coronary findings at autopsy in heart failure patients with sudden death: results from the assessment of treatment with lisinopril and survival (ATLAS) trial. Circulation (2000) 2.49
Cardiac troponin T and cardiac troponin I: relative values in short-term risk stratification of patients with acute coronary syndromes. GUSTO-IIa Investigators. Clin Chem (1998) 2.27
A comparison of U.S. and Canadian cardiac catheterization practices in detecting severe coronary artery disease after myocardial infarction: efficiency, yield and long-term implications. J Am Coll Cardiol (1999) 2.24
Effect of lipid-lowering therapy on early mortality after acute coronary syndromes: an observational study. Lancet (2001) 2.23
Value of serial troponin T measures for early and late risk stratification in patients with acute coronary syndromes. The GUSTO-IIa Investigators. Circulation (1998) 2.09
One-year results from the Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries (GUSTO-I) trial. GUSTO-I Investigators. Circulation (1996) 2.03
Thrombolysis in unstable angina. Randomized double-blind trial of t-PA and placebo. Circulation (1992) 1.97
Time from symptom onset to treatment and outcomes after thrombolytic therapy. GUSTO-1 Investigators. J Am Coll Cardiol (1996) 1.91
Detection of silent myocardial ischemia in diabetes mellitus. Am J Cardiol (1991) 1.78
Insights into the contemporary epidemiology and outpatient management of congestive heart failure. Am Heart J (1999) 1.75
Creatine kinase-MB elevation after percutaneous coronary intervention predicts adverse outcomes in patients with acute coronary syndromes. Eur Heart J (2004) 1.59
Incidence and predictors of bleeding events after fibrinolytic therapy with fibrin-specific agents: a comparison of TNK-tPA and rt-PA. Eur Heart J (2001) 1.58
A mammalian mitochondrial serine transfer RNA lacking the "dihydrouridine" loop and stem. Nucleic Acids Res (1980) 1.56
Time to treatment influences the impact of ST-segment resolution on one-year prognosis: insights from the assessment of the safety and efficacy of a new thrombolytic (ASSENT-2) trial. Circulation (2001) 1.56
Fibrillar collagen and remodeling of dilated canine left ventricle. Circulation (1990) 1.55
Efficacy and safety of high-dose lisinopril in chronic heart failure patients at high cardiovascular risk, including those with diabetes mellitus. Results from the ATLAS trial. Eur Heart J (2000) 1.55
Short- and long-term outcomes following atrial fibrillation in patients with acute coronary syndromes with or without ST-segment elevation. Heart (2008) 1.54
Non-invasive prediction of reperfusion and coronary artery patency by continuous ST segment monitoring in the GUSTO-I trial. Eur Heart J (1996) 1.52
Late assessment of thrombolytic efficacy (LATE) study: prognosis in patients with non-Q wave myocardial infarction. (LATE Study Investigators) J Am Coll Cardiol (1996) 1.48
Temporal evolution in the management of acute ST elevation myocardial infarction: the seven-year GUSTO experience from canada and the united states. The North American GUSTO-I and GUSTO-III investigators. Can J Cardiol (2000) 1.47
Coronary patency, infarct size and left ventricular function after thrombolytic therapy for acute myocardial infarction: results from the tissue plasminogen activator: Toronto (TPAT) placebo-controlled trial. TPAT Study Group. J Am Coll Cardiol (1991) 1.45
Angiographic morphology in unstable angina pectoris. Am J Cardiol (1988) 1.42
First experience with direct, selective factor Xa inhibition in patients with non-ST-elevation acute coronary syndromes: results of the XaNADU-ACS Trial. J Thromb Haemost (2005) 1.42
Risk of intracranial haemorrhage with combined fibrinolytic and glycoprotein IIb/IIIa inhibitor therapy in acute myocardial infarction. Dichotomous response as a function of age in the GUSTO V trial. Eur Heart J (2003) 1.42
Remodeling and reparation of the cardiovascular system. J Am Coll Cardiol (1992) 1.41
Does the discharge ECG provide additional prognostic insight(s) in non-ST elevation ACS patients from that acquired on admission? Eur Heart J (2003) 1.40
Heparin in acute coronary disease--requiem for a heavyweight? N Engl J Med (1997) 1.39
Management of asymptomatic chronic aortic regurgitation with left ventricular dysfunction: a decision analysis. J Gen Intern Med (1990) 1.39
Acute reduction of lipoprotein(a) by tissue-type plasminogen activator. Circulation (1992) 1.39
Adverse effects of corticosteroids on the cardiovascular system. Can J Cardiol (2000) 1.39
Prognosis in medically stabilized unstable angina: early Holter ST-segment monitoring compared with predischarge exercise thallium tomography. Ann Intern Med (1990) 1.38
Rapid ventricular pacing in the dog: pathophysiologic studies of heart failure. Circulation (1986) 1.38
Comparison of the appropriateness of coronary angiography and coronary artery bypass graft surgery between Canada and New York State. JAMA (1994) 1.35
The influence of changes in blood volume on angina pectoris. A study of the effect of phlebotomy. Circulation (1970) 1.29
Chronic false aneurysms of the left ventricle: management revisited. Can J Cardiol (1994) 1.28
Prognostic value of ST segment depression in acute coronary syndromes: insights from PARAGON-A applied to GUSTO-IIb. PARAGON-A and GUSTO IIb Investigators. Platelet IIb/IIIa Antagonism for the Reduction of Acute Global Organization Network. J Am Coll Cardiol (2001) 1.27
Swallow syncope. Can Med Assoc J (1985) 1.24
Blood levels after sublingual nitroglycerin. Circulation (1979) 1.22
27th Bethesda Conference: matching the intensity of risk factor management with the hazard for coronary disease events. Task Force 5. Stratification of patients into high, medium and low risk subgroups for purposes of risk factor management. J Am Coll Cardiol (1996) 1.17
Serum magnesium and potassium in acute myocardial infarction. Influence on ventricular arrhythmias. Arch Intern Med (1987) 1.16
Extracellular matrix remodeling after balloon angioplasty injury in a rabbit model of restenosis. Circ Res (1994) 1.16
Vasodilator therapy in acute myocardial infarction. A comparison of sodium nitroprusside and nitroglycerin. Circulation (1975) 1.11
Prior aspirin use predicts worse outcomes in patients with non-ST-elevation acute coronary syndromes. PURSUIT Investigators. Platelet IIb/IIIa in Unstable angina: Receptor Suppression Using Integrilin Therapy. Am J Cardiol (1999) 1.10
Pharmacokinetic-hemodynamic studies of nitroglycerin ointment in congestive heart failure. Am J Cardiol (1980) 1.09
Benefit of glycoprotein IIb/IIIa inhibition in patients with acute coronary syndromes and troponin t-positive status: the paragon-B troponin T substudy. Circulation (2001) 1.07
A predictive index for length of stay in the intensive care unit following cardiac surgery. CMAJ (1994) 1.04
Effect of nitroglycerin ointment on the clinical and hemodynamic response to exercise. Am J Cardiol (1976) 1.04
Differences in the treatment of myocardial infarction between the United States and Canada. A survey of physicians in the GUSTO trial. Med Care (1995) 1.03
Distribution of amiodarone and its metabolite, desethylamiodarone, in human tissues. Can J Physiol Pharmacol (1987) 1.02
Prediction of 1-year survival after thrombolysis for acute myocardial infarction in the global utilization of streptokinase and TPA for occluded coronary arteries trial. Circulation (2000) 1.02
Coronary revascularization after thrombolytic therapy for myocardial infarction: what caseloads could Canadian centres face? CMAJ (1989) 1.01
Amiodarone hepatotoxicity simulating alcoholic liver disease. N Engl J Med (1984) 1.01
Prinzmetal's angina, normal coronary arteries and pericarditis. Can Med Assoc J (1978) 1.00
Metaiodobenzylguanidine imaging in diabetes mellitus: assessment of cardiac sympathetic denervation and its relation to autonomic dysfunction and silent myocardial ischemia. J Am Coll Cardiol (1995) 0.98
Early recovery from heart failure: insights into the pathogenesis of experimental chronic pacing-induced heart failure. J Lab Clin Med (1988) 0.96
Pharmacokinetic-hemodynamic studies of intravenous nitroglycerin in congestive cardiac failure. Circulation (1980) 0.95
The complications of brachial arteriotomy. J Thorac Cardiovasc Surg (1971) 0.95
ST segment shift in unstable angina: pathophysiology and association with coronary anatomy and hospital outcome. J Am Coll Cardiol (1989) 0.94
Toleration of high doses of angiotensin-converting enzyme inhibitors in patients with chronic heart failure: results from the ATLAS trial. The Assessment of Treatment with Lisinopril and Survival. Arch Intern Med (2001) 0.94
Predictors of cardiogenic shock after thrombolytic therapy for acute myocardial infarction. J Am Coll Cardiol (2000) 0.94
Endothelium modulation of the effects of nitroglycerin on blood vessels from dogs with pacing-induced heart failure. Br J Pharmacol (1990) 0.93
Arterial-venous nitroglycerin gradient during intravenous infusion in man. Circulation (1982) 0.93
Rapid ventricular pacing of dogs to heart failure: biochemical and physiological studies. Can J Physiol Pharmacol (1990) 0.93
Prognostic significance of ST segment shift early after resolution of ST elevation in patients with myocardial infarction treated with thrombolytic therapy: the GUSTO-I ST Segment Monitoring Substudy. J Am Coll Cardiol (1998) 0.92
Incidence and impact on outcome of streptokinase allergy in the GUSTO-I trial. Global Utilization of Streptokinase and t-PA in Occluded Coronary Arteries. Am J Cardiol (1997) 0.92
Steady state pharmacokinetic haemodynamic studies of intravenous nitroglycerin in congestive cardiac failure. Br J Clin Pharmacol (1983) 0.91
Usefulness of ischemic response to mental stress in predicting silent myocardial ischemia during ambulatory monitoring. Am J Cardiol (1995) 0.91
Biases in the measurement of arterial pressure. Crit Care Med (1984) 0.90
Nuggets, pearls, and vignettes of master heart failure clinicians. Part 2-the physical examination. Congest Heart Fail (2002) 0.89
Pathophysiology and time course of silent myocardial ischaemia during mental stress: clinical, anatomical, and physiological correlates. Br Heart J (1995) 0.89
Reactivation of ischemic events in acute coronary syndromes: results from GUSTO-IIb. Gobal Use of Strategies To Open occluded arteries in acute coronary syndromes. J Am Coll Cardiol (2001) 0.88
Risk stratification with a point-of-care cardiac troponin T test in acute myocardial infarction. GUSTOIII Investigators. Global Use of Strategies To Open Occluded Coronary Arteries. Am J Cardiol (1999) 0.88
Noninvasive assessment of speed and stability of infarct-related artery reperfusion: results of the GUSTO ST segment monitoring study. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries. J Am Coll Cardiol (1995) 0.88
Evaluation of indices of left ventricular contractility and relaxation in evolving canine experimental heart failure. Cardiovasc Res (1992) 0.88
Clinical trial Data and Safety Monitoring Boards. The search for a constitution. Circulation (1995) 0.87
Intracoronary thrombus and complex morphology in unstable angina. Relation to timing of angiography and in-hospital cardiac events. Circulation (1989) 0.87
Atenolol use and clinical outcomes after thrombolysis for acute myocardial infarction: the GUSTO-I experience. Global Utilization of Streptokinase and TPA (alteplase) for Occluded Coronary Arteries. J Am Coll Cardiol (1998) 0.87
Progress in the treatment of acute coronary syndromes: a 50-year perspective (1950-2000). Circulation (2000) 0.87
Tolerance to organic nitrates: clinical and experimental perspectives. Am J Med (1983) 0.86